1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with vitamin d 2 in 1 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (vitamin d 2) | Trials (vitamin d 2) | Recent Studies (post-2010) (vitamin d 2) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 3,239 | 311 | 737 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alevizopoulou, F; Demopoulos, CA; Iatrou, C; Tsoupras, AB; Verouti, SN | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and vitamin d 2
| Article | Year |
|---|---|
Paricalcitol effects on activities and metabolism of platelet activating factor and on inflammatory cytokines in hemodialysis patients.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Acetyltransferases; Animals; Blood Platelets; Cytokines; Diacylglycerol Cholinephosphotransferase; Dose-Response Relationship, Drug; Ergocalciferols; Humans; Inflammation Mediators; Leukocytes; Pilot Projects; Platelet Activating Factor; Platelet Aggregation; Rabbits; Renal Dialysis; Renal Insufficiency, Chronic; Thrombin; Time Factors | 2013 |